Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis

Ophthalmologica

Volumn 221, Issue 3, 2007, Pages 153-158

  Uchio, Eiichi ^a   Itoh, Yuki ^b   Kadonosono, Kazuaki ^b  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Bromfenac sodium; Nonsteroidal anti inflammatory drug; Vernal keratoconjunctivitis

Indexed keywords

ANTIALLERGIC AGENT; BROMFENAC; CORTICOSTEROID; EYE DROPS; FLUOROMETHOLONE; PLACEBO; SODIUM CHLORIDE; TRANILAST;

ADOLESCENT; ADULT; ARTICLE; BLEPHARITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; FEMALE; HEPATITIS; HUMAN; LOCAL THERAPY; LONG TERM CARE; MALE; MAST CELL; RANDOMIZATION; RECURRENCE RISK; TOPICAL TREATMENT; VERNAL CONJUNCTIVITIS;

ADOLESCENT; ADULT; ANTHRANILIC ACIDS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOPHENONES; BROMOBENZENES; CHILD; CHILD, PRESCHOOL; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; CORNEA; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; OPHTHALMIC SOLUTIONS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247363189     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099294     Document Type: Article

References (31)

1. Bonini S, Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O, Rama P, Magrini L, Juhas T, Bucci MG: Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up. Ophthalmology 2000;107:1157-1163.
2. Buckley RJ: Vernal keratoconjunctivitis. Int Ophthalmol Clin 1988;28:303-308.
3. Foster CS: The pathophysiology of ocular allergy: current thinking. Allergy 1995;50(suppl 21):6-9.
4. Uchio E, Miyakawa K, Ikezawa Z, Ohno S: Systemic and local immunological features of atopic dermatitis patients with ocular complications. Br J Ophthalmol 1998;82:82-87.
5. Fujishima H, Takeuchi T, Shinozaki N, Saito I, Tsubota K: Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Immunol 1995;102:395-398.
6. Verin PH, Dicker ID, Mortemousque B: Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis. Clin Exp Allergy 1999;29:529-536.
7. BenEzra D: Current practice: diagnosis and treatment in primary healthcare. Allergy 1995;50(suppl 21):30-33.
8. Trocme SD, Raizman MB, Bartley GB: Medical therapy for ocular allergy. Mayo Clin Proc 1995;67:6-9.
9. Jerndal T, Munkby M: Corticosteroid response in dominant congenital glaucoma. Acta Ophthalmol (Copenh) 1978;56:373-383.
10. Bonini S, Lambiase A, Bonini S, Levi-Schaffer F, Aloe L: Nerve growth factor: an important molecule in allergic inflammation and tissue remodeling. Int Arch Allergy Immunol 1999;118:159-162.
11. El Hennawi M: A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis. Br J Ophthalmol 1994;78:365-369.
12. Gupta S, Khurana AK, Ahluwalia BK, Gupta NC: Topical indomethacin for vernal keratoconjunctivitis. Acta Ophthalmol (Copenh) 1991;69:95-98.
13. Laibovitz RA, Koester J, Schaich L, Reaves TA: Safety and efficacy of diclofenac sodium 0.1% ophthalmic solution in acute seasonal allergic conjunctivitis. J Ocul Pharmacol Ther 1995;11:361-368.
14. Tauber J, Raizman MB, Ostrov CS, Laibovitz RA, Abelson MB, Betts JG, Koester JM, Gill D, Schaich L: A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. J Ocul Pharmacol Ther 1998;14:137-145.
15. Ilic J, Gigon S, Leuenberger PM: Comparison of the anti-inflammatory effect of collyria of dexamethasone and diclofenac. Klin Monatsbl Augenheilkd 1984;184:494-498.
16. Friedlaender MH: The current and future therapy of allergic conjunctivitis. Curr Opin Ophthalmol 1998;9:54-58.
17. Friedlaender M: Overview of ocular allergy treatment. Curr Allergy Asthma Rep 2001;1:375-379.
18. Sharma A, Gupta R, Ram J, Gupta A: Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis. Indian J Ophthalmol 1997;45:177-180.
19. D'Angelo G, Lambiase A, Cortes M, Sgrulletta R, Pasqualetti R, Lamagna A, Bonini S: Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol 2003;241:192-195.
20. Sancilio LF, Nolan JC, Wagner LE, Ward JW: The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac. Drug Res 1987;37:513-519.
21. Miyake-Kashima M, Takano Y, Tanaka M, Satake Y, Kawakita T, Dogru M, Asano-Kato N, Fukagawa K, Fujishima H: Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis. Jpn J Ophthalmol 2004;48:587-590.
22. Hayasaka Y, Yayasaka S, Zhang X, Nagaki Y: Effects of topical corticosteroids and nonsteroidal anti-inflammatory drugs on prostaglandin E 2 -induced aqueous flare elevation in pigmented rabbits. Ophthalmic Res 2003;35:341-344.
23. BenEzra D: Guidelines on the diagnosis and treatment of conjunctivitis. Ocul Immunol Inflam 1994;2(suppl):17-26.
24. Sancilio LF, Reese DL, Cheung S, Alphin RS: AHR-5850: a potent anti-inflammatory compound. Agents Actions 1977;7:133-144.
25. Priddy AR, Killick SR, Elstein M, Morris J, Sullivan M, Patel L, Elder M: The effect of prostaglandin synthetase inhibitors on human preovulatory follicular fluid prostaglandin, thromboxane, and leukotriene concentrations. J Clin Endocrinol Metab 1990;71:235-242.
26. Nathan H, Naveh N, Meyer E: Levels of prostaglandin E 2 and leukotriene B 4 in tears of vernal conjunctivitis patients during a therapeutic trial with indomethacin. Doc Ophthalmol 1994;85:247-254.
27. Moses PL, Schroeder B, Alkhatib O, Ferrentino N, Suppan T, Lidofsky SD: Severe hepatotoxicity associated with bromfenac sodium. Am J Gastroenterol 1999;94:1393-1396.
28. Rabkin J, Smith MJ, Orloff SL, Corless CL, Stenzel P, Olyaei A: Fatal fulminant hepatitis associated with bromfenac use. Ann Pharmacol 1999;33:945-947.
29. Sharir M: Exacerbation of asthma by topical diclofenac. Arch Ophthalmol 1997;115:294-295.
30. Sheehan GJ, Kutzner MR, Chin WD: Acute asthma attack due to ophthalmic indomethacin. Ann Intern Med 1989;111:337-338.
31. Asai T, Nakagami T, Mochizuki M, Hata N, Tsuchiya T, Hotta Y: Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. Cornea 2006;25:224-227.